Boston Advisors’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-61,367
Closed -$3.86M 706
2016
Q2
$3.86M Buy
61,367
+14,711
+32% +$910K 0.1% 231
2016
Q1
$2.93M Buy
46,656
+3,256
+8% +$201K 0.07% 240
2015
Q4
$2.96M Buy
43,400
+11,956
+38% +$778K 0.07% 239
2015
Q3
$1.95M Sell
31,444
-1,631
-5% -$110K 0.07% 279
2015
Q2
$2.13M Buy
33,075
+740
+2% +$49.9K 0.09% 205
2015
Q1
$2.23M Buy
32,335
+11,785
+57% +$751K 0.09% 207
2014
Q4
$1.14M Sell
20,550
-58,600
-74% -$3.38M 0.05% 250
2014
Q3
$4.99M Buy
79,150
+57,100
+259% +$3.25M 0.21% 129
2014
Q2
$1.17M Buy
22,050
+15,360
+230% +$770K 0.05% 264
2014
Q1
$362K Sell
6,690
-210
-3% -$10.8K 0.02% 416
2013
Q4
$312K Buy
6,900
+850
+14% +$38.9K 0.01% 451
2013
Q3
$304K Hold
6,050
0.02% 414
2013
Q2
$278K Buy
+6,050
New +$266K 0.01% 426

Other funds holding PRXL

Boston Advisors's PRXL Position: Q3 2016 in Review

Boston Advisors sold out of Parexel International Corp (PRXL) in Q3 2016, closing a stake of 61,367 shares — an estimated $3.86M sold.

Boston Advisors first reported a position in PRXL in Q2 2013 and held it in 13 quarters. The position peaked at $4.99M in Q3 2014. 310 funds tracked by Wall St. Rank hold PRXL as of Q3 2016.

  • Boston Advisors reported no remaining Parexel International Corp position as of Q3 2016 after selling out during the quarter.
  • Boston Advisors sold 61,367 Parexel International Corp shares in Q3 2016, an estimated $3.86M.
  • Boston Advisors first reported a position in Parexel International Corp in Q2 2013 and held it in 13 quarters.
  • Boston Advisors's Parexel International Corp position peaked at $4.99M in Q3 2014.
  • 310 funds tracked by Wall St. Rank held Parexel International Corp as of Q3 2016.

Based on Boston Advisors's 13F filing for Q3 2016, filed 25 Oct 2016.